Back to search

Italy· 028675104

FLUSPIRAL*sosp inal 120 dosi 50 mcg

A corticosteroids, potent (group iii) product containing fluticasone, registered in Italy by A.MENARINI IND.FARM.RIUN.Srl, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC D07AC

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedFLUSPIRAL*sosp inal 120 dosi 50 mcgATCD07ACREGISTER NO.028675104PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Fluticasone is registered in 2 of 19 countries.

Countries holding a registration under ATC D07AC (corticosteroids, potent (group iii)), each read from that country’s own register.

  • This record: Italy
  • 2 of them publish a price we can compare per daily dose

Fluticasone · ATC D07AC

2 / 19 countries

  • Italyprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Fluticasone
Manufacturer
A.MENARINI IND.FARM.RIUN.Srl
Country
Italy (IT)
ATC code
D07AC
ATC class
Corticosteroids, potent (group III)
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    028675104
    FLUSPIRAL*sosp inal 120 dosi 50 mcg
    EUR 15.57

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Netherlands · Cortifil, Cutivate
  • Norway · Avamys, Flurhin
  • Poland · Cutivate, Fanipos
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c71e455d-be0a-4b58-88f3-b69055ac27dc
GET /v1/drugs/c71e455d-be0a-4b58-88f3-b69055ac27dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 15.57,
  "source": "aifa",
  "currency": "EUR",
  "strength": "FLUTICASONE 50MCG 120 DOSI USO RESPIRATORIO",
  "substance": "Fluticasone",
  "equivalence_group": "M8J",
  "transparency_flag": null
}

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.